Concepedia

Muzaffar H. Qazilbash

MH

Statistics

Publications

199

Citations

11.1K

H-Index

52

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Medical College of Wisconsin

University of California, San Francisco

University of Pennsylvania

Muzaffar H. Qazilbash is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, medicine, and stem cell transplantation.

ORCID

Publications per year

1995–2025

199

Publications

199

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

, , +15

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

Partow Kebriaei, Harjeet Singh, M. Helen Huls et al. · Journal of Clinical Investigation · 2016 · 504 citations · Full text

, , +17

Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture

Marcos de Lima, Ian McNiece, Simon N. Robinson et al. · New England Journal of Medicine · 2012 · 475 citations · Full text

, , +17

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

David Marín, Ye Li, Rafet Başar et al. · Nature Medicine · 2024 · 457 citations · Full text

, , +17

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

Amrita Krishnan, Marcelo C. Pasquini, Brent R. Logan et al. · The Lancet Oncology · 2011 · 277 citations

, , +15

1–5 of 199